ADAM1 activators cover a wide range of chemical classes, each with their unique mechanisms of action. Some compounds, such as phorbol esters, function as activators of Protein Kinase C (PKC), a family of enzymes that play critical roles in several signaling pathways. Through the activation of PKC, these compounds could potentially stimulate ADAM1 activation, especially if it is regulated via PKC-dependent pathways. Similarly, compounds like Calcium Ionophore A23187, which increase intracellular Ca2+ concentrations, might facilitate ADAM1 activation if the protein is calcium-responsive. Other chemical classes in this category include inhibitors of key enzymes in cellular signaling pathways, like EGFR tyrosine kinase inhibitors or PI3K inhibitors. By modulating these pathways, these compounds may indirectly lead to the activation of ADAM1. However, it's crucial to note that these interactions are complex, and the exact mechanisms by which these chemicals influence ADAM1 activation may vary.
All of these compounds, from phorbol esters to kinase inhibitors, form a diverse class of "ADAM1 activators." Each compound's potential to activate ADAM1 is based on its ability to interact with the protein directly or to modulate the cellular pathways that regulate ADAM1's function. While the field is still evolving, this class of compounds offers valuable tools for understanding the fundamental biology of ADAM1 and related proteins. As with all scientific endeavors, further research is required to fully elucidate the precise mechanisms of action and the broader implications of these chemical activators on ADAM1 and its biological roles.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates Protein Kinase C (PKC), which could potentially drive ADAM1 activation via PKC-dependent pathways | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Increases intracellular Ca2+ concentrations, potentially facilitating ADAM1 activation if it is calcium-dependent | ||||||
Calcium dibutyryladenosine cyclophosphate | 362-74-3 | sc-482205 | 25 mg | $147.00 | ||
A membrane-permeable analog of cyclic AMP, which could potentially promote ADAM1 activation via cAMP-dependent pathways | ||||||
Erlotinib Hydrochloride | 183319-69-9 | sc-202154 sc-202154A | 10 mg 25 mg | $75.00 $121.00 | 33 | |
Inhibits tyrosine kinases like EGFR, potentially triggering ADAM1 activation through EGFR signaling | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Another EGFR tyrosine kinase inhibitor, could potentially spark ADAM1 activation through EGFR signaling | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Inhibits PKC, potentially encouraging ADAM1 activation via PKC-dependent pathways | ||||||
Phorbol-12,13-dibutyrate | 37558-16-0 | sc-202285 | 1 mg | $124.00 | 3 | |
Activates PKC, potentially fostering ADAM1 activation via PKC signaling | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Blocks voltage-dependent L-type calcium channels, potentially enabling ADAM1 activation if it is calcium-dependent | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Inhibits BCR-ABL and other tyrosine kinases, potentially initiating ADAM1 activation through tyrosine kinase signaling pathways | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, potentially promoting ADAM1 activation via PI3K-dependent pathways | ||||||